Share this story:

Global Hemp Group Announces Consulting Agreemnts and Issuance of Options and Warrants



Global Hemp Group Inc.

Vancouver, BCTheNewswire - January 25, 2021 - GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE:GHG) / (OTC:GBHPF) / (FRANKFURT: GHG) (CNSX:GHG.CN) announces that pursuant to its stock option plan, it has granted stock options to purchase up to 5,300,000 common shares of the Company at an exercise price of $0.055 per share. The options have a term of five years expiring January 25, 2026 and shall vest in immediately.

The Company would also like to announce that it has entered into three consulting agreements (the "Consulting Agreements"). The first Consulting Agreement is with Twilight Capital Inc. ("Twilight") with respect to Twilight providing consulting services to support the Company’s business strategy in seeking various sources of funding. The second Consulting Agreement is with Prof. Víctor M. Castaño, Ph.D. with respect to acting as a R&D Advisor to the Company and to head GHG’s Research and Development Division, with the objective of creating Intellectual Property/patented technology that will be utilized at the Company’s projects and widely marketed throughout the United States. The third Consulting Agreement is with Gabriel Gauthier, a master hemp builder and pioneer in hemp construction in North America. Mr. Gauthier will advise on the utilization and application of hemp building materials and hemp construction for the Company's Colorado project

Terms of the consulting agreements, effective January 25, 2021, the Company to issue 3,000,000 warrants exercisable at the current market price, but in no case less than $0.05. These warrants will be exercisable for a period of five years from the date of issue and will vest six months after issuance. On the one year anniversary of the agreement the Company will issue an additional 4,000,000 warrants with an exercise price based on the previous 10 day VWAP, but in no case less than $0.05. The warrants will have a term of 5 years from the date of the one-year anniversary. On the two year anniversary of the agreement the Company will issue an additional 4,000,000 warrants with an exercise price based on the previous 10 day VWAP, but in no case less than $0.05. The warrants will have a term of 5 years from the date of the two year anniversary.

Warrants issued on the one year and two year anniversaries will vest in each year of issuance as follows:

- 50% of the yearly issuance on date of issuance, and

- the remaining 50% of the yearly issuance after 6 months from date of issuance

The Company and the Consultants maintain an arm's length relationship.

The Company will issue 9,000,000 common share purchase warrants (each a "Warrant") to the consultants of the Company. Each Warrant entitles the holder to acquire one common share of the Company at a price of $0.055 for a period of five (5) years from the date of issuance.  The Warrants were issued pursuant to the terms of consulting agreements entered into by the Company and each of the consultants and each Warrant was issued at a deemed value of $0.055 per Warrant.  All Warrants and underlying shares are subject to a four month hold period from the date of issuance.  The issuance of the Warrants is subject to the final approval of the CSE.

Like us on Facebook:  https://www.facebook.com/globalhempgrp

 

Follow us on Instagram: https://www.instagram.com/hemp_global/

 

Follow us on Twitter: https://twitter.com/Hemp_Global

About Global Hemp Group Inc.

Global Hemp Group Inc. (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG), is focused on a multi-phased strategy to build a strong presence in the industrial hemp industry the United States. The Company is headquartered in Vancouver, British Columbia, with hemp cultivation operations in the state of Oregon. The first phase of this strategy is to develop hemp cultivation for extraction of cannabinoids and the smokable CBG flower market with the objective of creating a near term revenue stream. The second phase of the strategy focuses on the development of value-added industrial hemp products utilizing the processing of the entirety of the hemp plant, as envisioned in the recently announced Colorado Hemp Agro-Industrial Zone (HAIZ) project. Global Hemp’s Research and Development Division headed by Prof. Víctor M. Castaño, Ph.D. Prof. Castaño, a recognized leader in several areas of applied science and technology brings an amazing wealth of knowledge and experience in a number of different disciplines. There are three immediate areas of interest that Prof. Castaño and his team will actively be focused on to develop Intellectual Property that can be patented and implemented in the hemp and/or building industry, and in particular at Company’s newly announced Colorado Hemp Agro-Industrial Zone.

For Further Information Contact Global Hemp Group

Tel: 424-354-2998

info@globalhempgroup.com

https://globalhempgroup.com

Cautionary Note Regarding Forward Looking Statements

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of Global Hemp Group Inc., including, but not limited to the impact of general economic conditions, industry conditions, volatility of commodity prices, currency fluctuations, dependence upon regulatory approvals, the availability of future financing and exploration risk, the legality of cannabis and hemp. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Except as required by law, Global Hemp Group Inc. disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

 

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.